Medicaid GLP-1 coverage in Texas, 2026.

Texas Medicaid does not cover Wegovy for weight loss.

What Texas Medicaid actually covers for Wegovy, Zepbound, Ozempic and Mounjaro. Most state Medicaid programs still exclude weight-loss-indication GLP-1, but the diabetes path is covered nearly everywhere with prior authorization (your doctor asks the plan to approve it first). Here is the current 2026 reality for Texas.

Coverage summary

IndicationCoverage
Wegovy (weight loss)No
Zepbound (weight loss)No
Ozempic / Mounjaro (type 2 diabetes)Yes
Compounded semaglutide / tirzepatideNo

Prior-authorization criteria

These rules come from the state preferred drug list (PDL), the list of drugs Texas Medicaid has agreed to pay for.

CriterionValue
PA burdenHigh
BMI threshold (weight-loss path)Not applicable (weight-loss path not covered)
Comorbidity requiredNo
Last PDL update reviewed2025-Q4

What this means in practice

Texas Medicaid follows the federal restriction on weight-loss medications and does not cover Wegovy or Zepbound. The diabetes indication is the practical path: Ozempic and Mounjaro require PA with A1c at least 7.5 percent and documented metformin trial. Texas STAR MCOs follow the state PDL.

Managed-care organizations in Texas (17 contracted)

Texas Medicaid contracts with the following managed-care organizations (MCOs), the private health plans the state pays to run day-to-day Medicaid coverage. MCO formularies must meet or exceed the state PDL but can layer in additional criteria. Verify your assigned MCO's most recent PA policy before submitting.

  • Superior HealthPlan (Centene)
  • Molina Healthcare of Texas
  • Amerigroup Texas (Anthem)
  • UnitedHealthcare Community Plan Texas
  • Aetna Better Health of Texas
  • Driscoll Health Plan

Cash-pay alternatives if Medicaid does not cover you

Cash-pay programs like Mochi ($178/mo) and compounded options are common in Texas. See /best/cheapest/ for ranked budget paths.

If you end up paying cash, the GLP-1 cost guide breaks down what every legitimate path actually costs at maintenance dose, from the $149-a-month compounded floor to branded manufacturer-direct pricing. For ranked cash-pay options, see programs ranked by price and programs under $150 a month. For manufacturer patient-assistance routes that bypass insurance entirely, see every cost-reduction pathway in 2026. For manufacturer savings cards and the Medicare Bridge, see the GLP-1 coupons and savings guide.

For the full cash-pay picture specific to Texas, including which programs serve Texas residents and the Texas Medicaid cost comparison, see the cheapest GLP-1 in Texas guide.

Take it to your prescriber: PA letter library

If you qualify under one of the covered indications above, the prior-authorization route is the cheapest path. We maintain a PA letter library with templates for Aetna, Cigna, UnitedHealthcare, Anthem BCBS, Kaiser, Humana, Tricare, FEHB and Medicare Advantage, cross-indexed against six qualifying clinical pictures. Each template cites the plan's policy document, the qualifying ICD-10 codes and the registration-trial evidence.

If you have type 2 diabetes plus chronic kidney disease and established cardiovascular disease, the triple-indication evidence stack (FLOW + SELECT + SUSTAIN-6) is the strongest PA path in any state.

If your PA is denied, the appeal letter library has denial-specific templates. For the commercial and Medicare coverage paths, see the GLP-1 insurance guide.

Texas Medicaid GLP-1 FAQ

Does Texas Medicaid cover Wegovy for weight loss?
No. Texas Medicaid does not cover Wegovy for the weight-loss indication as of the 2025-Q4 preferred drug list review. If you have type 2 diabetes, the diabetes-indicated GLP-1s (Ozempic, Mounjaro) may still be covered with prior authorization.
Does Texas Medicaid cover Zepbound for weight loss?
No. Texas Medicaid does not cover Zepbound for the weight-loss indication as of the 2025-Q4 preferred drug list review. If you have type 2 diabetes, Mounjaro (tirzepatide, the same molecule as Zepbound) may be covered with prior authorization under the diabetes pathway.
Does Texas Medicaid cover Ozempic or Mounjaro for diabetes?
Yes. Texas Medicaid covers Ozempic and Mounjaro for type 2 diabetes with prior authorization, usually after a trial of metformin. The diabetes pathway does not carry the BMI threshold that applies to the weight-loss pathway.
What if Texas Medicaid does not cover my GLP-1?
If your GLP-1 is not covered, the practical options are manufacturer patient-assistance programs (NovoCare for Wegovy, the Lilly savings programs for Zepbound), the diabetes pathway if you have type 2 diabetes, or cash-pay compounded semaglutide starting around $149 a month. Cash-pay programs like Mochi ($178/mo) and compounded options are common in Texas. See /best/cheapest/ for ranked budget paths. If you were denied, the appeal letter library has denial-specific templates.

Other state Medicaid pages

See the full 51-state coverage table for the side-by-side view across every US state.

How we built this page

Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.

Last updated: 2026-07-13. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Texas Medicaid, email hello@glpchart.com with the details and we will check it.

Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.